Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

Avadel Pharmaceuticals (AVDL) Insider Trading & Ownership

Avadel Pharmaceuticals logo

Avadel Pharmaceuticals (NASDAQ:AVDL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.20%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$903.86K
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$1.09M
Get AVDL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avadel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVDL Insider Buying and Selling by Quarter

Avadel Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/21/2025Buy5,000$7.93$39,650.00  
1/13/2025Buy10,000$8.04$80,400.00  
12/13/2024Buy2,300$10.44$24,012.00  
12/11/2024Buy5,000$10.49$52,450.00  
12/10/2024Buy20,279$9.84$199,545.36  
12/9/2024Buy402$9.82$3,947.64  
12/6/2024Buy9,598$9.98$95,788.04  
12/6/2024Buy3,000$10.19$30,570.00  
1/16/2024Buy2,000$14.50$29,000.00  
12/28/2023
Mark Anthony Mccamish
Director
Sell75,000$14.53$1,089,750.00  
8/14/2023Buy2,000$14.45$28,900.00  
8/10/2023Buy14,000$13.40$187,600.00  
8/10/2023Buy10,000$13.20$132,000.00  
(Data available from 1/1/2013 forward)

AVDL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Avadel Pharmaceuticals includes Geoffrey Michael Glass, Gregory J Divis, Linda Palczuk, Mark Anthony Mccamish, Peter J Thornton, and Thomas S Mchugh. Learn more on insiders at AVDL.

5.20% of Avadel Pharmaceuticals stock is owned by insiders. Learn more on AVDL's insider holdings.

The following insiders have purchased AVDL shares in the last 24 months: Geoffrey Michael Glass ($199,545.36), Gregory J Divis ($99,735.68), Linda Palczuk ($70,220.00), Peter J Thornton ($80,400.00), and Thomas S Mchugh ($76,462.00).

Insiders have purchased a total of 55,579 AVDL shares in the last 24 months for a total of $526,363.04 bought.



This page (NASDAQ:AVDL) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners